RecruitingPhase 3NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Phoenix, AZ · +40 more sites
5 recruiting multiple sclerosis studies with a site in Tucson, AZ.
Sponsor: Novartis Pharmaceuticals
Phoenix, AZ · +40 more sites
Sponsor: Sanofi
Phoenix, AZ · Scottsdale, AZ · Tucson, AZ · +31 more sites
Sponsor: Reunion Neuroscience Inc
Tucson, AZ · +31 more sites
Sponsor: AstraZeneca
Tucson, AZ · +8 more sites
Sponsor: AstraZeneca
Tucson, AZ · +7 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.